Rocket Pharmaceuticals Inc (RCKT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -47,594 | -223,123 | -180,585 | -130,253 | -61,334 |
| Depreciation Amortization | 2,146 | 11,287 | 8,808 | 5,568 | 2,989 |
| Accounts payable and accrued liabilities | -5,749 | -10,351 | N/A | N/A | -5,258 |
| Other Working Capital | -7,419 | -8,263 | -8,458 | 3,030 | -5,701 |
| Other Operating Activity | 13,222 | 40,436 | 25,061 | 16,901 | 13,514 |
| Operating Cash Flow | $-45,394 | $-190,014 | $-155,174 | $-104,754 | $-55,790 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 67,702 | -25,860 | N/A |
| PPE Investments | -93 | -440 | -360 | -414 | -364 |
| Purchase Of Investment | -48,709 | -276,553 | N/A | N/A | -139,931 |
| Sale Of Investment | 66,250 | 380,760 | N/A | N/A | 82,260 |
| Investing Cash Flow | $17,448 | $103,767 | $67,342 | $-26,274 | $-58,035 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1 | N/A | N/A | N/A | N/A |
| Common Stock Repurchased | N/A | -67 | -67 | N/A | N/A |
| Other Financing Activity | 0 | 215 | 215 | 215 | 0 |
| Financing Cash Flow | $-1 | $148 | $148 | $215 | $N/A |
| Beginning Cash Position | 78,898 | 164,997 | 164,997 | 164,997 | 164,997 |
| End Cash Position | 50,951 | 78,898 | 77,313 | 34,184 | 51,172 |
| Net Cash Flow | $-27,947 | $-86,099 | $-87,684 | $-130,813 | $-113,825 |
| Free Cash Flow | |||||
| Operating Cash Flow | -45,394 | -190,014 | -155,174 | -104,754 | -55,790 |
| Capital Expenditure | -93 | -440 | -360 | -414 | -364 |
| Free Cash Flow | -45,487 | -190,454 | -155,534 | -105,168 | -56,154 |